Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccine. Issue 7 (30th July 2021)

• Record Type: Journal Article
• Authors: Hines, Adam; Shen, Janice Gloria; Olazagasti, Coral; Shams, Shakil
• Is Part Of: BMJ case reports. Volume 14:Issue 7(2021)
• Publication Date: 2021-07-30
• Subjects: immunological products and vaccines -- hepatitis other -- haematology (incl blood transfusion) -- immunology -- public health; Medicine -- Case studies -- Periodicals; 610.5
• DOI: 10.1136/bcr-2021-242678
• Languages: English
• ISSNs: 1757-790X

Abstract

Abstract : A 26-year-old woman was sent to the emergency room by her primary care physician for a new petechial rash and thrombocytopenia 2 weeks after receiving the Moderna mRNA-1273 SARS-CoV-2 vaccine. Her hospital course was complicated by transaminitis. Her platelet count improved to normal on hospital day 5 after receiving intravenous steroids and intravenous immunoglobulin to treat her suspected diagnosis of immune thrombocytopenic purpura. Extensive workup for her thrombocytopenia and transaminitis was unremarkable including ruling out infectious, autoimmune and toxic causes. A liver biopsy was unrevealing and her transaminitis was improved on discharge. Although not proven, the temporal relationship of her vaccination with thrombocytopenia and abnormal liver enzymes points towards the Moderna mRNA-1273 SARS-CoV-2 vaccine as the most likely inciting factor.